» Authors » A Nortje

A Nortje

Explore the profile of A Nortje including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 73
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Curry B, van T Wout E, Maasdorp E, Nortje A, Irusen E, Maree D, et al.
Int J Tuberc Lung Dis . 2022 Feb; 26(3):259-267. PMID: 35197166
After TB treatment, many patients have post-TB lung disease (PTLD), associated with increased mortality and morbidity. Nevertheless, relationships between lung function testing and exercise capacity in people with PTLD are...
2.
Moolla M, Reddy K, Fwemba I, Nyasulu P, Taljaard J, Parker A, et al.
S Afr Med J . 2021 Aug; 111(6):575-581. PMID: 34382570
Background: Empirical broad-spectrum antibiotics are frequently prescribed to patients with severe COVID-19, motivated by concern about bacterial coinfection. There is no evidence of benefit from such a strategy, while the...
3.
Du Plessis E, Lalla U, Allwood B, Louw E, Nortje A, Parker A, et al.
S Afr Med J . 2021 Aug; 111(6):550-553. PMID: 34382564
The hyperinflammation seen as part of a dysregulated immune response to SARS-CoV-2 in its most severe form leads to acute respiratory distress syndrome (ARDS), multiorgan failure and death. Corticosteroid therapy...
4.
Parker A, Koegelenberg C, Moolla M, Louw E, Mowlana A, Nortje A, et al.
S Afr Med J . 2020 Nov; 110(10):982-987. PMID: 33205724
Background: South Africa (SA) has a high prevalence of HIV and tuberculosis. Cape Town was the SA metropole most affected in the early stages of the COVID-19 pandemic. Early observational...
5.
Lalla U, Allwood B, Louw E, Nortje A, Parker A, Taljaard J, et al.
S Afr Med J . 2020 Sep; 110(6):12941. PMID: 32880537
No abstract available.
6.
Koegelenberg C, Nortje A, Lalla U, Enslin A, Irusen E, Rosenkranz B, et al.
S Afr Med J . 2013 Jun; 103(6):394-8. PMID: 23725959
Background: There is a paucity of data on the pharmacokinetics of fixed-dose combination enteral antituberculosis treatment in critically ill patients. Objectives: To establish the pharmacokinetic profile of a fixed-dose combination...